PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • CalerieHealth®β-NMN 6,000


    DIETARY SUPPLEMENT

    ----------

    CalerieHealth®
    β-NMN 6,000

    β-NMN 6,000

    NMN (Nicotinamide Mononucleotide) is a derivative of Vitamin B3 that is converted by your body into Nicotinamide Adenine Dinucleotide (NAD+).

    NAD+ is found in all living cells and is necessary for metabolism to convert the food we eat into cellular energy.

    Poor aging and a number of related ailments are linked to low levels of NAD+. NMN may promote optimal aging, energy and cognition by supporting healthy NAD+.*

    Directions

    Take two (2) Chewable Tablets per day with breakfast or between meals on an empty stomach.

    Supplement Facts
    Serving Size 2 Chewable Tablets
    Servings Per Container 30
    Amount Per Serving %DV
    *
    Daily Value not established.
    β-Nicotinamide Mononucleotide (Premium Grade 99.9%) 200mg*

    Other Ingredients: Non-GMO D-Glucan, Natural Blueberry Flavor, Organic Monk Fruit Extract, Vegetable-Source Magnesium Stearate.

    Shelf Life: 24 months.

    Keep out of reach of children. Keep in a cool, dry place at room temperature. Seek the advice of a healthcare professional prior to use if you are pregnant or taking any medications.

    Manufactured & Packed
    For CalerieHealth Holding LLC
    Address: 200 Spectrum Center Dr, Suite 2100
    Irvine, CA 92618
    Info at:
    www.calerie.com
    info@calerie.com
    (877) 922-5374

    *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    PRODUCT PHOTO

    NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

    The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected over dosage, the drug's identity should be verified by chemical analysis.

    Image from Drug Label Content